国际生殖健康/计划生育杂志 ›› 2023, Vol. 42 ›› Issue (5): 371-376.doi: 10.12280/gjszjk.20230094

• 论著 • 上一篇    下一篇

一例产前Silver-Russell综合征胎儿的基因变异分析

杨玉婷, 惠玲, 陈雪, 张钏, 田芯瑗, 周秉博()   

  1. 730050 兰州,甘肃省妇幼保健院/甘肃省中心医院医学遗传中心,甘肃省出生缺陷与罕见病临床研究中心
  • 收稿日期:2023-03-03 出版日期:2023-09-15 发布日期:2023-09-13
  • 通讯作者: 周秉博 E-mail:15293110286@163.com
  • 基金资助:
    甘肃省科技计划项目(21JR7RA680);甘肃省科技计划项目(22YF7FA094);甘肃省科技计划项目(21JR1RA045);兰州市科技计划项目(2021-1-182);兰州市科技计划项目(2022-5-81)

Genetic Variation Analysis of A Prenatal Fetus with Silver-Russell Syndrome

YANG Yu-ting, HUI Ling, CHEN Xue, ZHANG Chuan, TIAN Xin-yuan, ZHOU Bing-bo()   

  1. Medical Genetics Center, Gansu Provincial Maternity and Child-Care Hospital/Gansu Provincial Central Hospital, Gansu Provincial Clinical Research Center for Birth Defects and Rare Diseases, Lanzhou 730050, China
  • Received:2023-03-03 Published:2023-09-15 Online:2023-09-13
  • Contact: ZHOU Bing-bo E-mail:15293110286@163.com

摘要:

目的: 对1例产前B超提示骨骼系统发育异常,疑似宫内生长受限的胎儿进行基因检测及生物信息学分析以明确其致病原因。方法: 采集胎儿羊水及父母外周血,提取基因组DNA,利用高通量测序平台进行家系全外显子组测序(whole exome sequencing,WES)及拷贝数变异测序(copy number variation sequencing,CNV-seq)技术检测,可疑结果经Sanger测序进行验证。结果: 胎儿高迁移率族蛋白A2(high mobility group protein AT-Hook-2,HMGA2)基因存在c.223C>T(p.R75W)新发变异,导致氨基酸改变为p.R75W(p.Arg75Trp),为错义突变。根据美国医学遗传学与基因组学学会(American College of Medical Genetics and Genomics,ACMG)指南评级,该变异判定为可能致病性(likely pathogenic):PS2+PM2_Supporting+PP3+PS4_Supporting。根据其临床表型,该胎儿被确诊为常染色体显性遗传的Silver-Russell综合征5型(Silver-Russell syndrome 5,SRS5)。Sanger测序确证了其变异的真实性。结论: HMGA2基因的c.223C>T(p.R75W)杂合致病性变异可能是SRS5的遗传学致病原因,扩充了该基因的变异谱,同时为该胎儿的产前遗传咨询和后续的干预措施提供了理论依据。

关键词: Silver-Russell综合征, 高迁移率族蛋白质类, 全外显子组测序, DNA拷贝数变异, 胎儿生长迟缓

Abstract:

Objective: A fetus was suggested the developmental abnormity of skeletal system and suspected growth restriction by prenatal B-ultrasound. To clarify the cause of the disease, genetic detection and bioinformatics analysis were conducted. Methods: gDNAs were extracted from the amniotic fluid of proband and the peripheral blood of his parents, respectively. Whole exome sequencing (WES) and copy number variation sequencing (CNV-seq) technique of trio via high-throughput sequencing platforms, and Sanger sequencing were used to verify the likely pathogenic variant. Results: A denovo mutation of c.223C>T(p.R75W) in the fetal high mobility group protein AT-Hook-2(HMGA2) gene was found. It is a missense mutation, resulting in the change of amino acid to p.R75W (p.Arg75Trp). According to American College of Medical Genetics and Genomics (ACMG), the variant was assessed to be a likely pathogenic variant: PS2+PM2_Supporting+PP3+PS4_Supporting. Based on the clinical phenotype, the fetus was diagnosed with an autosomal dominant Silver-Russell syndrome 5 (SRS5). Sanger sequencing confirmed the authenticity of the mutation. Conclusions: The c.223C>T(p.R75W) of HMGA2 gene may be the genetic cause of the heterozygous pathogenic variation, which expands the variant profile of this gene and provides a theoretical basis for prenatal genetic counseling and subsequent interventions in the fetus.

Key words: Silver-Russell syndrome, High mobility group proteins, Whole exome sequencing, DNA copy number variations, Fetal growth retardation